Search for Clinical Trial Results

Sponsored By

Limb-girdle Muscular Dystrophy - 19 Studies Found

Status Study
Completed Study Name: Cell Therapy in Limb Girdle Muscular Dystrophy
Condition: Limb Girdle Muscular Dystrophy
Date: 2014-09-12
Interventions: Biological: Stem Cell
Completed Study Name: Stem Cell Therapy in Limb Girdle Muscular Dystrophy
Condition: Limb Girdle Muscular Dystrophy
Date: 2014-01-29
Interventions: Biological: Autologous bone marrow mononuclear cell transplantation bone marrow derived mononuclear cell
Active, not recruiting Study Name: Genetic Characterization of Individuals With Limb Girdle Muscular Dystrophy
Condition: Limb-Girdle Muscular Dystrophy
Date: 2007-04-06
Completed Study Name: Clinical Study of AAV1-gamma-sarcoglycan Gene Therapy for Limb Girdle Muscular Dystrophy Type 2C
Condition:
  • Limb Girdle Muscular Dystrophy Type 2C
  • Gamma-sarcoglycanopathy<
    Date: 2011-03-17
    Interventions: Biological: AAV1-gamma-sarcoglycan vector injection single intramuscular injection into carpi radialis m
Completed Study Name: Evaluation of Limb-Girdle Muscular Dystrophy
Condition:
  • Becker Muscular Dystrophy
  • Limb-Girdle Muscular Dystrophy, Type
    Date: 2009-05-04
Recruiting Study Name: Limb Girdle Muscular Dystrophy (LGMD) Natural History
Condition: Muscular Dystrophies, Limb-Girdle (GENETICALLY CONFIRMED)
Date: 2013-01-18
Completed Study Name: MRI on Persons With Mutations in POMT2 Gene (LGMD2N)
Condition: Limb-girdle Muscular Dystrophy
Date: 2016-04-27
Completed Study Name: MRI and Muscle Involvement in Patients With Mutations in GMPPB
Condition: Limb-girdle Muscular Dystrophy
Date: 2015-12-01
Enrolling by invitation Study Name: Gene Transfer Clinical Trial for LGMD2D (Alpha-sarcoglycan Deficiency) Using scAAVrh74.tMCK.hSGCA
Condition: Limb Girdle Muscular Dystrophy Type 2D (LGMD2D)
Date: 2013-07-24
Interventions: Drug: scAAVrh74.tMCK.hSGCA
Completed Study Name: Gene Transfer Therapy for Treating Children and Adults With Limb Girdle Muscular Dystrophy Type 2D (LGMD2D)
Condition: Muscular Dystrophies
Date: 2007-06-27
Interventions:
  • Genetic: rAAV1.tMCK.human-alpha-sarcoglycan- First cohort

Next >>>